SP

Sohan Pralhadachand Agrawal

Active Director Director DIN 11420361
DIN 11420361 First appointment Dec 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sohan Pralhadachand Agrawal

Data last updated:

Sohan Pralhadachand Agrawal is a Director at R & G Pharma International Private Limited (since 2025).

DIN 11420361
Primary Designation Director
First Appointment 10 Dec 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Dec 20252025Active

Board colleagues of Sohan Pralhadachand Agrawal

NameDINCompanyDesignation
Rahul Verma11420362R & G Pharma International Private LimitedDirector

Directorship timeline

Open interactive timeline →
R & G Pharma International Private Limited
Premium access

Shareholding and investment profile for Sohan Pralhadachand Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sohan Pralhadachand Agrawal

Sohan Pralhadachand Agrawal currently holds 1 directorship: R & G Pharma International Private Limited (Director, since 10 Dec 2025).

Sohan Pralhadachand Agrawal was first appointed on 10 Dec 2025 as Director at R & G Pharma International Private Limited.

The current boards of Sohan Pralhadachand Agrawal's companies include Rahul Verma (R & G Pharma International Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available